We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$2.54B
Cap. Flow
+$1.55B
Cap. Flow %
7.41%
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$798M
2
XOM icon
ExxonMobil
XOM
+$189M
3
CTSH icon
Cognizant
CTSH
+$86.4M
4
MRK icon
Merck
MRK
+$80.6M
5
IART icon
Integra LifeSciences
IART
+$47.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$57.5M
2
PEP icon
PepsiCo
PEP
+$55.1M
3
DG icon
Dollar General
DG
+$49.7M
4
WOOF
VCA Inc.
WOOF
+$48.1M
5
SPG icon
Simon Property Group
SPG
+$45.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.52%
2 Technology 14.11%
3 Financials 12.07%
4 Industrials 10.58%
5 Consumer Discretionary 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
R icon
1751
Ryder
R
$10.3B
$12K ﹤0.01%
165
+65
+65% +$4.92K
SBS icon
1752
Sabesp
SBS
$19.7B
$12K ﹤0.01%
6,394
VNO.PRL icon
1753
Vornado Realty Trust 5.40% Series L Preferred Shares
VNO.PRL
$209M
$12K ﹤0.01%
500
WFC.PRL icon
1754
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$12K ﹤0.01%
10
GNMK
1755
DELISTED
GenMark Diagnostics, Inc
GNMK
$12K ﹤0.01%
1,000
WFT
1756
DELISTED
Weatherford International plc
WFT
$12K ﹤0.01%
1,917
+1,832
+2,155% +$10.7K
FRC.PRC.CL
1757
DELISTED
First Republic Bank
FRC.PRC.CL
$12K ﹤0.01%
500
PVTB
1758
DELISTED
PrivateBancorp Inc
PVTB
$12K ﹤0.01%
203
HW
1759
DELISTED
Headwaters Inc
HW
$12K ﹤0.01%
547
-722,574
-100% -$16.8M
FTR
1760
DELISTED
Frontier Communications Corp.
FTR
$12K ﹤0.01%
419
-31
-7% -$1.42K
CY
1761
DELISTED
Cypress Semiconductor
CY
$12K ﹤0.01%
873
+294
+51% +$3.76K
GOLD
1762
DELISTED
Randgold Resources Ltd
GOLD
$12K ﹤0.01%
146
TCF
1763
DELISTED
TCF Financial Corporation
TCF
$12K ﹤0.01%
740
-185,220
-100% -$3.29M
ARE icon
1764
Alexandria Real Estate Equities
ARE
$8.88B
$11K ﹤0.01%
105
CIG icon
1765
CEMIG Preferred Shares
CIG
$6.09B
$11K ﹤0.01%
7,325
+1,469
+25% +$2.29K
DXCM icon
1766
DexCom
DXCM
$27.6B
$11K ﹤0.01%
564
-228
-29% -$4.45K
EDU icon
1767
New Oriental
EDU
$7.84B
$11K ﹤0.01%
196
ETSY icon
1768
Etsy
ETSY
$7.65B
$11K ﹤0.01%
1,171
+1,000
+585% +$11.7K
GFF icon
1769
Griffon
GFF
$4.16B
$11K ﹤0.01%
451
+111
+33% +$2.77K
GPI icon
1770
Group 1 Automotive
GPI
$3.94B
$11K ﹤0.01%
155
+43
+38% +$3.36K
HLF icon
1771
Herbalife
HLF
$1.23B
$11K ﹤0.01%
406
-102
-20% -$2.84K
JHX icon
1772
James Hardie Industries
JHX
$15.4B
$11K ﹤0.01%
715
NRC icon
1773
NRC Health Common Stock
NRC
$474M
$11K ﹤0.01%
575
SXT icon
1774
Sensient Technologies
SXT
$5.4B
$11K ﹤0.01%
150
TEI
1775
Templeton Emerging Markets Income Fund
TEI
$310M
$11K ﹤0.01%
1,000

Similar funds

Glenmede Trust's Q1 2017 Portfolio in Review

As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.

  • Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
  • Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
  • Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
  • Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
  • Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
  • Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
  • Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.